Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Inactivators of Toxoplasma gondii ornithine aminotransferase for treating toxoplasmosis and malaria

Inactivators of Toxoplasma gondii ornithine aminotransferase for treating toxoplasmosis and malaria

US Patent 10632088 · Granted Apr 28, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Fluorine substituted cyclohexene analogues of gamma-aminobutyric acid (GABA)2025
Systems and methods for optical flow estimation2025
L-γ-methyleneglutamine compounds and methods of use2025
Process for the synthesis of (s) 3-amino-4-(difluoromethylenyl)cyclopent-1-ene-12025
Substituted fused pyrimidine compounds and uses thereof2025
Method for controlling production of excessive water and aqueous fluids in oil a2025
Potent and selective human neuronal nitric oxide synthase inhibitors2025
Bacterial nitric oxide synthase inhibitors2025
Use of neuronal nitric oxide synthase inhibitors for immunotherapy in melanoma p2024
3-amino-4-halocyclopentene carboxylic acids as inactivators of aminotransferases2024
Toxoplasma gondii vaccines and their use2024
Compounds and methods for treating, detecting, and identifying compounds to trea2024